Naslov
European collaboration on relative effectiveness assessments: What is needed to be successful?

Autori
Kleijnen, Sarah ; Toenders, Wil ; de Groot, Folkert ; Huic, Mirjana ; George, Elisabeth ; Wieseler, Beate ; Pavlovic, Mira ; Bucsics, Anna ; Siviero, Paolo D. ; van der Graaff, Martin ; Rdzany, Rafał ; Kristensen, Finn Børlum ; Goettsch, Wim

Izvornik
Health Policy (0168-8510) 119 (2015), 5; 569-576

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
Relative effectiveness Relative effectiveness assessment PharmaceuticalsHealth technology assessment European collaboration Reimbursement
(Relative effectivenessRelative effectiveness assessmentPharmaceuticalsHealth technology assessmentEuropean collaborationReimbursement)

Sažetak
Objective: The objective of this study is to identify the possible barriers and critical success factors for the implementation of European collaboration in the field of relative effectiveness assessment (REA) of drugs. Methods: Data were gathered through semi- structured interviews with representatives from eight European health technology assessment (HTA) organisations involved in assessment of drugs for coverage decision-making (AAZ, AIFA, AHTAPol, HAS, HVB, IQWIG, NICE and ZiN). Results: Potential barriers identified mainly relate to methodology, resources and challenges with implementation in the respective national processes (e.g. legal restrictions). The most critical success factors for production of cross- border assessments were the continuous cooperation of competent partners, and the quality and timely availability of the assessment. Conclusion: Further adaptation of the process and methods is required for optimal collaboration. In the near future it can be expected that cross- border assessments will meet in particular the needs of smaller/middle-sized European countries and also European countries with less developed HTA systems as the potential efficiency/quality gains are the highest for these countries. Therefore, national implementation of cross-border assessments is especially likely in these countries in the coming years. Once more experience is gained with cross-border assessments, and successes become more evident, efficiency/quality gains may also be likely for some larger countries with well established processes.

Izvorni jezik
Hrvatski

Znanstvena područja
Kliničke medicinske znanosti, Javno zdravstvo i zdravstvena zaštita

POVEZANOST RADA